NCT03814356View on ClinicalTrials.gov

Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

April 1, 2024

Study Completion Date

August 1, 2025

Conditions
Brain Injury Traumatic Severe (Diagnosis)ComaConsciousness, Level AlteredAnoxic Brain Injury
Interventions
DRUG

Methylphenidate

IV MPH

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER